Xiangcheng Li Selected Research

Xiangcheng Li Research Topics

Disease

35	Neoplasms (Cancer) 02/2024 - 09/2011
16	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 09/2011
14	Cholangiocarcinoma 04/2024 - 01/2012
5	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2013
5	Ischemia 11/2020 - 06/2010
4	Reperfusion Injury 04/2024 - 07/2010
4	Carcinogenesis 11/2023 - 08/2014
4	Necrosis 11/2023 - 07/2010
4	Hypoxia (Hypoxemia) 10/2023 - 01/2014
3	Fatty Liver 04/2024 - 01/2014
3	Klatskin Tumor 01/2022 - 08/2019
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 11/2021 - 01/2018
3	Fibrosis (Cirrhosis) 05/2015 - 10/2002
3	Inflammation (Inflammations) 01/2015 - 01/2014
2	Hemorrhage 02/2023 - 07/2007
2	Liver Neoplasms (Liver Cancer) 01/2022 - 12/2021
2	Carcinoma (Carcinomatosis) 04/2021 - 01/2018
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 06/2010
2	Non-alcoholic Fatty Liver Disease 01/2020 - 05/2015
2	Wounds and Injuries (Trauma) 01/2014 - 06/2010
2	Hepatitis B 07/2007 - 10/2002
2	Hepatolenticular Degeneration (Wilson's Disease) 10/2002 - 04/2002
1	Alcoholic Fatty Liver 04/2024
1	Biliary Fistula 02/2023
1	Gallbladder Neoplasms (Gallbladder Cancer) 11/2021
1	Infertility (Sterility) 11/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Lymphatic Metastasis 01/2021

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 04/2024 - 07/2010
8	Biomarkers (Surrogate Marker)IBA 05/2023 - 01/2012
6	MicroRNAs (MicroRNA)IBA 11/2023 - 08/2017
3	EnzymesIBA 01/2024 - 01/2015
3	RNA (Ribonucleic Acid)IBA 10/2023 - 09/2020
3	Long Noncoding RNAIBA 01/2023 - 01/2019
3	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2020
2	Sirtuin 1IBA 04/2024 - 01/2015
2	Fatty Acids (Saturated Fatty Acids)IBA 04/2024 - 10/2023
2	Circular RNAIBA 01/2024 - 01/2021
2	Gemcitabine FDA Link 11/2023 - 11/2020
2	BilirubinIBA 02/2023 - 06/2010
2	6-propylchromone-2-carboxylic acid (PCCA)IBA 01/2022 - 10/2020
2	camrelizumabIBA 01/2022 - 11/2020
2	Caspase 3 (Caspase-3)IBA 12/2021 - 01/2015
2	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 05/2013
2	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 10/2002
2	Cantharidin (Cantharides)IBA 07/2020 - 10/2015
2	norcantharidinIBA 07/2020 - 10/2015
2	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 01/2018
2	Small Interfering RNA (siRNA)IBA 01/2019 - 10/2015
2	Oxidoreductases (Dehydrogenase)IBA 01/2018 - 04/2002
2	Alanine Transaminase (SGPT)IBA 05/2015 - 06/2010
2	polyolIBA 01/2015 - 01/2014
2	NAD (NADH)IBA 01/2015 - 01/2014
2	Heme Oxygenase-1IBA 12/2014 - 01/2014
1	CateninsIBA 04/2024
1	Protein Isoforms (Isoforms)IBA 04/2024
1	cis-trans-IsomerasesIBA 02/2024
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 02/2024
1	Ubiquitin-Specific ProteasesIBA 01/2024
1	trametinibIBA 01/2024
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 10/2023
1	Coenzyme A Ligases (Acid-Thiol Ligases)IBA 05/2023
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 02/2023
1	C-Reactive ProteinIBA 02/2023
1	sintilimabIBA 01/2022
1	Sincalide FDA Link 01/2022
1	anlotinibIBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	apatinibIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021
1	HydrogelsIBA 12/2021
1	PyrogensIBA 11/2021
1	EndotoxinsIBA 11/2021
1	HaptoglobinsIBA 04/2021
1	Competitive Endogenous RNAIBA 01/2021
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2021
1	Cyclin D1IBA 01/2021
1	Adenosine Triphosphatases (ATPase)IBA 01/2021
1	IntegrinsIBA 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2020
1	Interleukin-17 (Interleukin 17)IBA 11/2020
1	LipidsIBA 01/2020
1	Sterol Regulatory Element Binding Protein 1IBA 01/2020
1	Nonesterified Fatty Acids (NEFA)IBA 01/2020
1	Tripartite Motif ProteinsIBA 05/2019
1	cinobufaginIBA 01/2019

Therapy/Procedure

4	Liver Transplantation 11/2020 - 07/2007
3	Therapeutics 04/2022 - 02/2014
2	Immunotherapy 04/2024 - 11/2021
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2022
2	Hepatectomy 01/2022 - 11/2020
2	Transplantation 12/2013 - 07/2007
1	Perioperative Period 01/2022
1	Neoadjuvant Therapy 01/2022
1	Adjuvant Chemotherapy 01/2022
1	Aftercare (After-Treatment) 01/2022
1	Lymph Node Excision (Lymph Node Dissection) 08/2019